TC
ABBV icon

TwinBeech Capital’s AbbVie ABBV Stock Holding History

TwinBeech Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-57,870
Closed -$10.7M – 537
2025
Q2 		$10.7M Buy
+57,870
New +$10.8M 0.24% 114
2024
Q2 		– Sell
-173,088
Closed -$31.5M – 496
2024
Q1 		$31.5M Buy
+173,088
New +$29.8M 0.65% 48
2022
Q1 		– Sell
-26,152
Closed -$3.54M – 468
2021
Q4 		$3.54M Buy
+26,152
New +$3.09M 0.2% 147
2021
Q3 		– Sell
-61,358
Closed -$6.91M – 544
2021
Q2 		$6.91M Buy
+61,358
New +$6.91M 0.84% 26
2020
Q4 		– Sell
-46,139
Closed -$4.04M – 414
2020
Q3 		$4.04M Buy
+46,139
New +$4.34M 0.88% 20

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TwinBeech Capital's ABBV Position: Q3 2025 in Review

TwinBeech Capital sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 57,870 shares — an estimated $10.7M sold.

TwinBeech Capital first reported a position in ABBV in Q3 2020 and held it in 5 quarters. The position peaked at $31.5M in Q1 2024. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • TwinBeech Capital reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • TwinBeech Capital sold 57,870 AbbVie shares in Q3 2025, an estimated $10.7M.
  • TwinBeech Capital first reported a position in AbbVie in Q3 2020 and held it in 5 quarters.
  • TwinBeech Capital's AbbVie position peaked at $31.5M in Q1 2024.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on TwinBeech Capital's 13F filing for Q3 2025, filed 14 Nov 2025.